Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 1
1998 1
2000 2
2001 4
2002 3
2003 4
2004 3
2005 6
2006 8
2007 7
2008 6
2009 9
2010 9
2011 13
2012 31
2013 30
2014 21
2015 17
2016 22
2017 34
2018 23
2019 25
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21383220

255 results
Results by year
Filters applied: . Clear all
Page 1
Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.
O'Connor A, Alto W, Musgrave K, Gibbons D, Llanto L, Holden S, Karnes J. O'Connor A, et al. J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201. doi: 10.3122/jabfm.2011.02.100155. J Am Board Fam Med. 2011. PMID: 21383220 Free article.
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J, Heilig M, Sarman I. Kakko J, et al. Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19. Drug Alcohol Depend. 2008. PMID: 18355989
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB, Collett A, Alto WA, O'Brien LM. O'Connor AB, et al. J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009. J Midwifery Womens Health. 2013. PMID: 23931660
Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?
O'Connor AB, O'Brien L, Alto WA. O'Connor AB, et al. J Perinat Med. 2013 Sep 1;41(5):621-3. doi: 10.1515/jpm-2012-0288. J Perinat Med. 2013. PMID: 23612625
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K, Morrone WR, O'Grady KE, Jones HE. Debelak K, et al. Am J Addict. 2013 May-Jun;22(3):252-4. doi: 10.1111/j.1521-0391.2012.12005.x. Am J Addict. 2013. PMID: 23617867
Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Bakstad B, et al. Eur Addict Res. 2009;15(3):128-34. doi: 10.1159/000210042. Epub 2009 Mar 31. Eur Addict Res. 2009. PMID: 19332991
Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV, Katz E, Weitz B, Visconti K. Towers CV, et al. Am J Obstet Gynecol. 2020 Jan;222(1):83.e1-83.e8. doi: 10.1016/j.ajog.2019.07.037. Epub 2019 Jul 31. Am J Obstet Gynecol. 2020. PMID: 31376396
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Stitzer ML. Stitzer ML. Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x. Addiction. 2013. PMID: 23331877 No abstract available.
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L. Jones HE, et al. Drug Alcohol Depend. 2005 Jul;79(1):1-10. doi: 10.1016/j.drugalcdep.2004.11.013. Drug Alcohol Depend. 2005. PMID: 15943939 Clinical Trial.
Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G. Unger A, et al. Addiction. 2011 Jul;106(7):1355-62. doi: 10.1111/j.1360-0443.2011.03440.x. Epub 2011 May 12. Addiction. 2011. PMID: 21438938 Free PMC article. Clinical Trial.
255 results
Jump to page